FLT3

CAT # Inoa Huahana wehewehe
CPDB0099 Quizartinib; AC-010220; AC-220 ʻO Quizartinib kahi mea pale o FMS pili tyrosine kinase 3 (FLT3; Kd = 1.6 nM) a hōʻike i ke koho kiʻekiʻe no FLT3 ke hoʻāʻo ʻia e kūʻē i kahi panel o 227 kinases hou. Hoʻopaʻa ia i ka hoʻonui ʻana o ka laina cell leukemia kanaka MV4-11, kahi i hoʻopaʻa ʻia i ka homozygous FLT3-ITD mutation, me kahi waiwai IC50 o 0.56 nM.1 Ma 1 mg / kg / lā, ua hōʻike ʻia ʻo quizartinib e hoʻolōʻihi i ke ola ʻana i ka ʻiole. kumu hoʻohālike o FLT3-ITD acute myeloid leukemia a no ka hoʻopau ʻana i nā maʻi koko i loko o ka ʻiole hilinaʻi FLT3 kŘkohu xenograft ma 10 mg/kg.
,

Kāhea iā mā˚ou

Ninau

Nuhou Hou

  • ʻO 7 ʻoi loa ma ka noiʻi lāʻau lapaʻau ma 2018

    ʻO 7 ʻoi loa i ka noiʻi lāʻau lapaʻau I...

    Ma lalo o ka piʻi nui ʻana o ka hoʻokūkū e hoʻokūkū i kahi ʻenehana paʻakikī a me ka ʻenehana, pono e hoʻomau nā ʻoihana lāʻau lapaʻau a me biotech i kā lākou papahana R&D e noho i mua ...

  • ARS-1620: He mea hoʻohiki hou no nā maʻi maʻi KRAS-mutant

    ARS-1620: He mea hoʻohiki hou no K...

    Wahi a kahi noiʻi i paʻi ʻia ma Cell, ua hoʻomohala nā mea noiʻi i kahi inhibitor kūikawā no KRASG12C i kapa ʻia ʻo ARS-1602 i hoʻoulu i ka regression tumor i nā ʻiole. "Ke hāʻawi nei kēia haʻawina i nā hōʻike vivo e hiki ke lilo i mutant KRAS ...

  • Loaʻa iā AstraZeneca ka hoʻoikaika kānāwai no nā lāʻau lapaʻau oncology

    Loaʻa iā AstraZeneca ka hoʻonui hoʻoponopono no...

    Ua loaʻa iā AstraZeneca kahi hoʻonui pālua no kāna kōpili oncology i ka Pōʻalua, ma hope o ka ʻae ʻana o nā regulators US a me ʻEulopa i nā hoʻouna kānāwai no kāna mau lāʻau lapaʻau, ʻo ka hana mua i ka lanakila ʻana i kēia mau lāʻau lapaʻau. ...

WhatsApp Online Chat !